n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, May 1st, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Lightwave Logic, Inc. (LWLG)

SmallCapVoice, PennyStocks24, SmallCap Fortunes, StockGuru, FeedBlitz, OTC Picks, Standout Stocks, and HotOTC reported earlier on Lightwave Logic, Inc. (LWLG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lightwave Logic is a technology business concentrating on the development of Next Generation Photonic Devices and Non Linear Optical Polymer Materials Systems for applications in high-speed fiber-optic data communications and optical computing. The Company creates prototype electro-optic demonstration devices. A development stage company, Lightwave Logic is based in Longmont, Colorado and the Company’s shares trade on the OTCQB.

Lightwave Logic is moving toward commercialization of next generation photonic devices utilizing its high-activity and high-stability organic polymers for applications in data communications and telecommunications markets. Lightwave Logic is using organic nonlinear electro-optical and all-optical polymers (plastic) as the foundation for a series of proprietary (internal and licensed to external partners) advanced Integrated Optical Devices that have wide-ranging application in telecommunications, data communications, and optical computing for use in commercial and military markets.   
 
The Company has integrated its proprietary Perkinamine™ chromophore technology with other chromophores based in part on aspects of proprietary, in-licensed technologies. This has resulted in a strong and durable nonlinear organic electro-optical (EO) material that will be used in photonic device development. It is based on its multi-chromophore approach, which enables two or more chromophores to work together.  

Lightwave Logic has a planned photonic device program. It has successfully completed the fabrication of organic polymer ridge waveguide structures with its core material. The Company has a number of U.S. and international patent applications. These encompass its composition of matter and spacer systems. Patents have been issued covering its basic Heterocyclical Chromophore Architecture and the Tricyclic Spacer systems.  

Last week, Lightwave Logic announced that it attained bandwidth suitable for 25Gbps data rates in an all-organic polymer ridge waveguide intensity modulator prototype. The Company said that this is a major improvement over its initial 10Gbps device modulator earlier reported on December 26, 2016.

Mr. Tom Zelibor, Lightwave Logic’s Chief Executive Officer, said, "Less than two-quarters from our initial 10Gbps waveguide modulator press release, our engineering team has pushed the performance to where we can now address the explosive 100Gbps market for optical modulators. Enabled by our P2IC™ polymer system, our prototype device is suitable for data rates at 25Gbps, and we believe it can be scaled further to operate up to 50Gbps…”

Lightwave Logic, Inc. (LWLG), closed Monday's trading session at $1.18, up 12.38%, on 562,779 volume with 486 trades. The average volume for the last 60 days is 84,971 and the stock's 52-week low/high is $0.50/$1.05.

RepliCel Life Sciences, Inc. (REPCF)

Streetwise Reports, Greenbackers, The Green Baron, Club Penny Stocks Network, Investor Spec Sheet, StockGuru, TheStockAdvisor, 24-7 Stock Alert, Beacon Equity Research, Crazy Carl, Global Equity Report, InvestorSoup, OTCPicks, Penny Stock Explosion, Penny Stocks Finder, ShazamStocks, SmallCapReview, Stock Preacher, and StockHideout reported on RepliCel Life Sciences, Inc. (REPCF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

RepliCel Life Sciences, Inc. is a regenerative medicine company listed on the OTC Markets’ OTCQB. The Company concentrates on the development of cell therapies for aesthetic and orthopedic conditions.  These include aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. All of the Company’s product candidates are based on RepliCel’s inventive technology using cell populations isolated from a patient's healthy hair follicles. RepliCel Life Sciences has its corporate headquarters in Vancouver, British Columbia.

The Company's product pipeline consists of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. At present, RCH-01 is being co-developed with and under exclusive license by Shiseido for certain Asian countries. In addition, RepliCel has developed a proprietary injection device RCI-02, optimized for the administration of its products and licensable for use with other dermatology applications.

RepliCel is investing in research, which it states has the potential to lead to many future products. This includes other chronic tendinopathies (patellar tendinosis, tennis elbow, golfer’s elbow, rotator cuff); other dermatologic indications (acne scaring, etc.); gingivitis, and allogeneic versions of RepliCel’s proven autologous cell therapies.

Earlier this month, RepliCel Life Sciences reported statistically and clinically significant positive data from the interim analysis of its Phase I study evaluating RCS-01 for the treatment of aging and sun-damaged skin. The main goal of the trial was to establish a complete safety profile for intradermal injections of RCS-01 (the Company’s type 1 collagen-expressing, hair follicle-derived fibroblasts [NBDS cells]) at six months’ post-injection.

Participants in the Germany-based study did not report any serious adverse events at the interim point of the trial. Moreover, researchers gathered convincing positive proof-of-concept data indicating the product's potential for skin rejuvenation.

Last week, RepliCel Life Sciences announced the granting of a key patent in the United States (U.S. Patent No. 9,616,182) covering significant components of its novel, multi-needle dermal injection device. The patent issued by the USPTO relates to technologies designed to enable unparalleled control and repeatable consistency of needle action and product deposition.

Furthermore, the patent relates to the element designed to numb the skin before injection with the intended effect of lessening, if not eliminating, the need for local anesthetic before aesthetic injection procedures. The first device being developed under this patent is RCI-02. 

RepliCel Life Sciences, Inc. (REPCF), closed Monday's trading session at $0.6709, down 4.82%, on 69,136 volume with 55 trades. The average volume for the last 60 days is 60,352 and the stock's 52-week low/high is $0.4281/$1.469.

Spotlight Innovation, Inc. (STLT)

Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Penny Picks, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Beacon Equity Research, Penny Stock Finder, Stock Preacher, SuperStockTips, InvestorSoup, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. A pharmaceutical Company, Spotlight identifies and acquires rights to unique and proprietary platform technology candidates. The Company’s emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and unique opportunities. OTCQB-listed, Spotlight Innovation is based in Urbandale, Iowa.

Spotlight Innovation provides solutions for healthcare-focused companies commercializing healthcare intellectual property (IP). Spotlight will partner with proven market leaders through sale, out-license, or strategic alliance, when commercially significant benchmarks have been reached.

The Company works to acquire the rights, via acquisition, license, or otherwise, to inventive and proprietary Platform Technology Candidates. Also, it works to provide value-added development capability and funding to attain fast IND approval to start human clinicals for targeted Platform Technology Candidates.     

Spotlight’s mission is to greatly impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates is achieved through its extensive relationships with many top academic institutions and other sources. The Company provides value-added development capability and funding to speed up development progress.

Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive worldwide rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection. In February 2017, Spotlight announced that it entered into a second license agreement with FSURF for the development and commercialization of additional anti-Zika virus compounds.

As with the first license agreement, this agreement grants to the Company exclusive, global rights to develop and commercialize certain compounds for the treatment of viral infections, including Zika virus infection.

Spotlight Innovation announced in February that it engaged a top-tier contract research organization (CRO) to conduct additional preclinical mouse studies of STL-182, Spotlight’s proprietary small molecule product candidate for the treatment of spinal muscular atrophy (SMA). Synthesis and early preclinical testing of STL-182 was accomplished via a research collaboration between Professors Elliot Androphy of Indiana University School of Medicine and Mr. Kevin Hodgetts, Director of the Laboratory for Drug Discovery in Neurodegeneration at Brigham and Women's Hospital. Professor Androphy and Professor Hodgetts are members of Spotlight Innovation's Scientific Advisory Board.

This past March, Spotlight Innovation announced that it started Part 2 of a Phase 1 Cancer Trial. The Company announced that its subsidiary, Celtic Biotech, began Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. ImmunoClin Ltd. is the contract research organization (CRO) overseeing the study conduct. ImmunoClin specializes in clinical development.

Spotlight Innovation, Inc. (STLT), closed Monday's trading session at $0.33, down 5.71%, on 3,420 volume with 13 trades. The average volume for the last 60 days is 55,634 and the stock's 52-week low/high is $0.254/$1.75.

Aphria, Inc. (APHQF)

CFN Media Group and Cannabis Financial Network News reported on Aphria, Inc. (APHQF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Aphria, Inc. is one of Canada's lowest cost producers that produces, supplies, and sells medical cannabis. The Company works to provide pharmaceutical-grade medical cannabis, and premier patient care. Its devotion is to do this while balancing patient economics and returns to shareholders. Aphria has its headquarters in Leamington, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

Aphria’s medical cannabis products are 100 percent greenhouse grown. The Company’s commitment is to ensuring patients receive consistent, safe, and effective medical cannabis products. The Company is a Health Canada Licensed Producer of medical cannabis products. The only legal access to medical cannabis in Canada is via Health Canada Licensed Producers. Nonetheless, some Canadians still have personal production licenses. This grants them authorization to produce medical cannabis for personal use.

Aphria’s cannabis oil products are produced employing C02 extraction methods. These methods preserve purity and ensure safety. Aphria’s equivalency factor of cannabis oil to dried cannabis is 6:1. As a result, every 6 mL of cannabis oil is equivalent to 1 gram of dried cannabis.

Frequently, an appropriate dose for new patients using THC cannabis oil is 0.5-1.5mL. Patients are always registered within 48 hours. Patients may order the amount of cannabis oil that is equivalent to the amount of dried cannabis prescribed on their medical document.

Aphria is in the middle of a multi-phase expansion program. Upon completion of Part II, it expects that yearly production capacity will reach 5,500 kilograms of dried cannabis and 9,000 liters of cannabis oil.

Last month, Tetra Bio-Pharma, Inc. (GRPOF) and Aphria announced plans for the joint distribution of dried medical cannabis in the maritime provinces and Quebec. Tetra Bio-Pharma and Aphria will enter into a joint supply agreement. Aphria will supply dried medical cannabis under its ACMPR license. Tetra will package the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001.

Tetra will complete the formulation and packaging, under its CDSA dealer's licence, at its New Brunswick facility. Tetra Bio-Pharma is a multi subsidiary company engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Aphria, Inc. (APHQF), closed Monday's trading session at $4.79, up 5.74%, on 291,858 volume with 984 trades. The average volume for the last 60 days is 252,532 and the stock's 52-week low/high is $0.98/$6.60.

Solis Tek, Inc. (SLTK)

We are reporting on Solis Tek, Inc. (SLTK) today, here at the QualityStocks Daily Newsletter.

Solis Tek, Inc. is a vertically integrated technology innovator, developer, manufacturer, and distributor. Its focus is on bringing products and solutions to commercial cannabis growers in legal markets throughout the United States. The Company’s emphasis is on the research, design, development, and manufacturing of advanced and efficient lighting products. Solis Tek has its corporate headquarters in Carson, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company offers a wide-ranging line of lighting equipment and accessories to help its customers realize higher yields and maximize quality. Solis Tek product categories include complete systems; digital ballasts, DE Lamps; SE Lamps; CMH Lamps; Reflectors; and accessories. Solis Tek’s customers include retail stores, distributors, as well as commercial growers in the U.S. and internationally.

Solis Tek’s technology encompasses Ignition Control; SenseSmart™, as well as the industry’s lowest output THD (Total Harmonic Distortion) percent. The Company states that its ballasts offer the industry's only true Ignition Control staggered ignition technology. Solis Tek's sequential lamp ignition technology will ignite lamps one at a time based on load stability.

The Company’s SenseSmart™ will check for eight different factors before attempting to power the lamp. The intention of this is increased user safety. SenseSmart™ checks for open output; high/low temperatures; ignition failure; thermal; end of lamp life; overflow current; over/low voltage; and short circuit.

At end of March 2017, Solis Tek reported record Revenues for the year ended December 31, 2016 of $8,563,751 versus Revenue of $7,713,456 the year prior. This represents an 11 percent increase in Revenue over 2015. Gross Profit for the years ended December 31, 2016 and 2015, was $3,123,859 and $2,719,036, respectively.

The Company’s Gross Margins grew to 36.5 percent up from 35.3 percent the year prior. Moreover, Solis Tek’s Cash balances increased 159 percent year over year. In addition, the Company Won Dope Magazine's 2016 Best Lighting Company Award.

Solis Tek, Inc. (SLTK), closed Monday's trading session at $1.91, up 11.05%, on 273,313 volume with 402 trades. The average volume for the last 60 days is 66,425 and the stock's 52-week low/high is $0.25/$1.72.

graphic

The QualityStocks
Company Corner

graphic
graphic

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.16, even for the day, on 3,420 volume with 13 trades. The stock’s average daily volume over the past 60 days is 55,634 and its 52-week low/high is $0.254/$1.75.

Consilium Global Research (CGR), an investor recognition company that connects companies and investors, today announced that it issued an Executive Summary on Chinese Investors.com, Inc. (OTCQB: CIIX). The executive summary is available on Stock Market Manager (smm.global) here: Company Profile; Executive Profile.
 
The 4 page Executive Summary has several segments: company overview, key highlights, benefits of CBD Oil, industry analysis, Comparable analysis, financial highlights, SWOT analysis and updates. 

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

Consilium Global Research Issues Executive Summary on Chinese Investors.com, Inc. (OTCQB: CIIX)

ChineseInvestors.com, Inc. Announces 3Q Financial Results, Posts Nearly 100% YoY Increase, Expects Hemp Products to Generate Substantial Revenues in 2018

ChineseInvestors.com to Attend 'Invest 2017' Exhibition in Stuttgart, Germany

CD International Enterprises, Inc. (CDII)

The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.0103, off by 17.60%, on 717,836 volume with 21 trades. The stock’s average daily volume over the past 60 days is 1,401,040 and its 52-week low/high is $0.0001/$20.00.

CD International Enterprises, Inc. today announced it has engaged E & E Communications for Public and Investor Relations Services. "E & E Communications will provide CD International with the level of strategic planning and day-to-day investor and public relations services that will allow management to focus on our ongoing business expansion in cannabidiol (CBD) products. E & E Communications will guide the Company in developing an investor and public relations program that supports its goals and creates shareholder value," said Dr. James Wang, Chairman and CEO of CD International.

CD International Enterprises, Inc. (CDII) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.CD International Enterprises, Inc., CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

CD International Enterprises, Inc. Blog

CD International Enterprises, Inc. News:

CD International Enterprises, Inc. (CDII) Announces Engagement of E & E Communications for Public and Investor Relations Services

CD International Enterprises Enters a Wholesale Distribution Agreement Including Products for Relaxation and Flavored Hemp Oils

CD International Enterprises Enters Partnership Agent Sales Agreement with NutraFuels, Inc.

Players Network, Inc. (PNTV)

The QualityStocks Daily Newsletter would like to spotlight Players Network, Inc. (PNTV). Today, Players Network, Inc. closed trading at $0.0625, up 14.26%, on 2,286,164 volume with 125 trades. The stock’s average daily volume over the past 60 days is 1,577,836, and its 52-week low/high is $0.0022/$0.055.

Players Network, Inc. (PNTV) is a diversified holding company operating in marijuana and media. PNTV owns 86% of Green Leaf Farms Holdings, LLC (Green Leaf Farms) which has Nevada state-issued cultivation and production license(s). The cultivation license enables Green Leaf Farms to grow marijuana and the production license enables them to create extracts which are used for cartridges, oils and edibles. WeedTV.com is a wholly owned subsidiary which is developing the ultimate resource for the marijuana lifestyle. PNTV has been a fully reporting, publicly traded company since 1998.

Green Leaf Farms Holdings, LLC (Green Leaf)

Green Leaf produces medical and recreational cannabis products. Revenues are generated by selling their cannabis products to licensed dispensaries throughout Nevada.

Their mission is to produce the highest quality and safest pharmaceutical-grade cannabis to all levels of consumers. They utilize the most efficient cultivation methods in order to lower expenses for consumers and to maximize returns for investors.

They are a privately held company with a unique business model as they are one of only a few companies who have been granted 2 (two) Medical Marijuana Establishment (MME) licenses in Nevada; Cultivation and Production.

Their Cultivation License enables them to grow cannabis which will produce flower. Their Production License enables them to process flower (cannabis) and cannabis byproducts into extremely pure concentrates, extracts, and oils which are used in medicine, cartridges and edibles. Green Leaf has both acquired and developed proprietary cannabis strains and will continue to be committed to cannabis research and development.

Green Leaf is located in North Las Vegas, Nevada on 2.3 acres in a state-of-the-art 26,000 sq. ft. facility. They have a seasoned team of professional growers and operators to manage the facility with proven best practices to ensure they have the highest quality products available.

WeedTV.com

WeedTV.Com is a niche social network and lifestyle channel destination for the marijuana industry. They are developing the "go-to" source for information, entertainment, products and services for people who relate to the marijuana lifestyle and an active social community. WeedTV.com features daily stories sourced by WeedTV.com correspondents and contributors from around the world.

Programming includes, political news, business news on the industry, financial analysis from industry experts, growing tips, cooking tips, the "Weed101" section, medical applications/issues, lifestyle features, and entertainment specials.

WeedTV.com's first original series is titled "High Stakes." High Stakes was developed by Michael Berk, the company's Chief Creative Officer and creator of one of the most popular cable series of all time, Baywatch. High Stakes is docu-series that follows the team at Green Leaf Farms as they build their facility and launch their marijuana business.

By leveraging media, WeedTV.com builds long-term brand equity and connects consumers to businesses. This is accomplished through fresh and relevant content such as professionally produced branded television segments, user-generated videos, blogs, editorials, tweets (twitter), photos, special offers, events and custom-designed contests to engage both consumers and businesses with their brands and services.

Marijuana and Media Strategy

While developing WeedTV.com, the PNTV team realized they could implement a vertical strategy to utilize their media platform (WeedTV.com) to drive business and awareness to their cannabis products (Green Leaf Farms). Through the audience and reach of WeedTV.com, they will build brand value and cross market their own marijuana products, as well as generate revenues by marketing other companies' products and services. Disclaimer

Players Network, Inc. Company Blog

Players Network, Inc. News:

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Issues Update on WeedTV.com, Plans to Launch Beta

Player's Network CEO Provides 1Q Shareholder Update, Outlook

Players Network (OTCQB: PNTV) Featured on MoneyTV with Donald Baillargeon, 2/17

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0746, up 8.12%, on 16,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 98,150, and its 52-week low/high is $0.025/$0.65.

Grey Cloak Tech, Inc. (GRCK) is a developer of industry-leading click-fraud detection software designed to overcome the most expensive and devastating threats in the digital world. Through its recently acquired subsidiary, ShareRails, Grey Cloak now also provides sophisticated e-commerce tools that help retailers evolve beyond their brick-and-mortar business practices to increase both their digital engagement and their foot traffic.

ShareRails is an online-to-offline technology firm that provides vitally important services within the trillion-dollar retail sector, helping brick-and-mortar retailers compete directly for online awareness with e-commerce-only brands. Through the ShareRails O2O platform, offline retailers can use online channels to more effectively drive sales and attract new customers.

The innovative solutions offered by ShareRails enable local retailers to capture the millions of online shopping searches they are currently missing out on because their product inventories and other key information is not currently available online and, therefore, does not appear in relevant searches and cannot be viewed digitally.

Most of today's retail sales are Web-influenced. By utilizing digital marketing channels, merchants can enhance the in-store shopping experience for customers and simultaneously boost sales. The ShareRails O2O platform enables retailers to put their product catalogs online, along with product location and availability, and make the information searchable. The platform also offers digital merchandising tools that include an outfit builder and wishlist app along with conversational shopping tools. Through ShareRails O2O, merchants can additionally tap into data that details shopper insights and behavioral trends. Add-on services include click-n-collect, reservations for in-store pickup, and local delivery.

ShareRails additionally offers Dress.li, which is a recommendation and reward platform that connects shoppers to stylists, bloggers and other fashion influencers who provide them with expert shopping advice and uniquely styled looks and, simultaneously, connects the consumers to fashion retailers. Through Dress.li, the challenge of creating a seamless social shopping experience has finally been mastered! This platform facilitates live shopping communications, curation and content creation and lets users join a global network of trendsetters. Through this network, users can inspire and be inspired, accessing and sharing product recommendations and unique looks and receiving rewards each time another user makes a purchase from their recommendations. This platform not only provides an enjoyable and exciting network for shoppers and fashionistas, but it simultaneously supplies retailers with a lucrative outlet for acquiring new customers through a built-in global sales force of fashion influencers. As these Dress.li stylists create and share looks, they also deliver pre-qualified sales leads and conversions and are rewarded for doing so.

Joined together, Grey Cloak Tech's industry-leading click-fraud detection solutions and the exciting retail-boosting products delivered through ShareRails offer a broad package of services to both protect businesses in the digital world and help them utilize digital channels to bolster their sales and enhance customer engagement.

Grey Cloak Tech continues to serve as an industry leader in developing the most effective and comprehensive weapons to fight online security threats. The company is keenly focused on protecting its clients' interests through the identification of fraud patterns at the very earliest stages. When businesses partner with Grey Cloak Tech, they can look forward to benefiting from industry-leading technology, a top-tier client services team, and an augmented bottom line. Disclaimer

Grey Cloak Tech, Inc. Company Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech Completes the Acquisition of ShareRails O2O E-commerce Services Platform

Grey Cloak Tech, Inc. (GRCK) is “One to Watch”

Grey Cloak Tech Announces 70 Percent Increase in Quarterly Revenues and 74 Percent Increase in Revenues YTD in 2016

National Waste Management Holdings, Inc. (NWMH)

The QualityStocks Daily Newsletter would like to spotlight National Waste Management Holdings, Inc. (NWMH). Today, National Waste Management Holdings, Inc. closed trading at $0.10, up 3.57%, on 216,450 volume, with 14 trades. The stock’s average daily volume over the past 60 days is 18,114, and its 52-week low/high is $0.06/$0.41.

National Waste Management Holdings, Inc. (NWMH) is a solid waste management company offering comprehensive solutions for full waste diversion along Florida's west coast and in upstate New York. With an established base of long-term partnerships with municipal, institutional, commercial and industrial customers, along with a successful acquisition strategy, National Waste has set its course to become a leading waste diversion company.

National Waste's 54-acre landfill facility located in Hernando, Florida, handles annual average disposals of roughly 240,000 cubic yards of construction debris annually. The site also offers an array of ancillary services such as roll-off dumpster services, mulching services and recycling. While the landfill facility is already permitted for future expansion, National Waste's growth strategy also calls for the opening of new satellite offices in counties and states that neighbor its existing operations.

In addition to increasing its geographic foothold, National Waste employs a strategic acquisition model to increase its overall market share. In 2015, the company acquired Gateway Rolloff Services LP and Waste Recovery Enterprises LLC, which are expected to generate a combined $3.8 million in annual revenue for National Waste moving forward. In the second quarter of 2016, National Waste added Sivart Services to its roster, creating an immediate source of additional revenue and expanding its foothold in the northeast area of New York.

Management has confirmed its interest in additional acquisition targets while demonstrating its ability to effectively integrate and organically grow the company's existing acquisition companies and maintain efficient operations. Disclaimer

National Waste Management Holdings, Inc. Company Blog

National Waste Management Holdings, Inc. News:

National Waste Management Holdings Inc. Reports Full-Year 2016 Results, Triple-Digit Revenue Growth

National Waste Management Holdings, Inc. Expands Territory with Acquisition of Burts Refuse, LLC

National Waste Management Holdings, Inc. (NWMH) Expands Market Reach in New York with Acquisition of Northeast Data Destruction and Recycling

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(LMFAW) +132.22%

2.

Wall Street Mover
(MTBC) +76.47%

3.

Small Cap Firm
(WEQL) +57.08%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251